Established in fall 2008, the BTEC scholarship program provides financial assistance to selected students pursuing an undergraduate minor in biomanufacturing. Scholarships are funded by biomanufacturing and biotechnology companies that do business in the RTP area and beyond. Currently, scholarships are between $2,000–$3,000 per academic year.
To be considered for a BTEC scholarship, students must meet the following criteria:
- Full-time NC State University student
- Officially declared in the undergraduate minor
Additionally, sponsors may specify additional requirements, such as:
- Specific majors (e.g., engineering and/or life sciences)
- Junior and senior standing only
- Merit based
- Financial need
Students may be awarded only one BTEC scholarship per academic year. Funds are disbursed on a semester basis to the recipient's university account. Students who are attending for only one semester during an academic year are still eligible for a BTEC scholarship as long as they meet all eligibility requirements.
Apply for a BTEC Scholarship
To be considered for a BTEC scholarship, students need to register with Pack Assist and fill out the general scholarship application. There is not a specific application for BTEC scholarships, so it is important to fill out the essay portion indicating your interest in biomanufacturing.
The scholarship committee considers the following items when selecting recipients:
- Specific requirements based on scholarship sponsor
- Interest in careers in biomanufacturing, evaluated through scholarship essay, co-curricular activities, and internships
- Overall GPA and/or grades in BEC courses
Networking and responsibilities
Receiving a BTEC scholarship is an excellent opportunity for students to network with their sponsor. As such, we ask that students send a thank-you letter to their sponsor. In addition, students typically have an opportunity to attend a networking event with BTEC scholarship sponsors. (No scholarship networking event in fall 2021 due to COVID-19.)
Novartis Gene Therapies
Formerly known as AveXis, Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases.
Well known for its Zolgensma gene therapy treatment for spinal muscular atrophy (SMA), Novartis Gene Therapies has developed a reproducible manufacturing process to address rare genetic disorders.
Novartis Gene Therapies has a manufacturing site in Durham, N.C.
MilliporeSigma aims to solve the toughest problems in life science by collaborating with the global scientific community—and through that, aims to accelerate access to better health for people everywhere.
MilliporeSigma supports over 300,000 products, 60 manufacturing sites, 130 life science distribution centers, and 20,000 employees worldwide through its three business sectors:
- Life Science
MilliporeSigma offers support to students worldwide.
For companies interested in supporting our students, please contact BTEC's assistant director of academic programs to discuss funding opportunities.
For students with questions about scholarship eligibility, contact the manager of student programs.